Business

Announcement on Voluntary Disclosure of Progress in Milestone Payment Received for Signing Authorization License and Progress in Commercialization Agreement with STADA for BAT2506 (Golimumab) Injection

Announcement on Voluntary Disclosure of Progress in Milestone Payment Received for Signing Authorization License and Progress in Commercialization Agreement with STADA for BAT2506 (Golimumab) Injection

articleBio-thera Solutions, Ltd. Class AMarch 26, 20265/news/announcement-on-voluntary-disclosure-of-progress-in-milestone-payment-received-for-signing-authorization-license-and-progress-in-commercialization-agreement-with-stada-for-bat2506-golimumab-injection
Announcement on Voluntary Disclosure of Progress in Milestone Payment Received for Signing Authorization License and Progress in Commercialization Agreement with STADA for BAT2506 (Golimumab) Injection

About this update from Bio-thera Solutions, Ltd. Class A

Announcement on Voluntary Disclosure of Progress in Milestone Payment Received for Signing Authorization License and Progress in Commercialization Agreement with STADA for BAT2506 (Golimumab) Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Bio-thera Solutions, Ltd. Class A